Improved Mood and Behavior during Treatment with a Mineral-Vitamin Supplement: An Open-Label Case Series of Children

Journal of Child and Adolescent Psychopharmacology

Volumn 14, Issue 1, 2004, Pages 115-122

  Kaplan, Bonnie J ^a,b   Fisher, Jennifer E ^c   Crawford, Susan G ^b   Field, Catherine J ^d   Kolb, Bryan ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; DEXAMPHETAMINE; FLUOXETINE; METHYLPHENIDATE; MINERAL; PAROXETINE; RISPERIDONE; VITAMIN;

ADOLESCENT; AGITATION; ARTICLE; ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIPOLAR DISORDER; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EXCITABILITY; FEMALE; GASTROINTESTINAL DISEASE; GENERALIZED ANXIETY DISORDER; HEADACHE; HUMAN; MALE; MANIA; MOOD DISORDER; NAUSEA; NUTRIENT; OBSESSIVE COMPULSIVE DISORDER; OUTCOMES RESEARCH; QUESTIONNAIRE; RATING SCALE; SCHOOL CHILD; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VITAMIN SUPPLEMENTATION; VOMITING;

ADOLESCENT; BEHAVIORAL SYMPTOMS; CHILD; CHILD BEHAVIOR DISORDERS; FEMALE; HUMANS; MALE; MINERALS; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; VITAMINS;

EID: 1942475187     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454604773840553     Document Type: Article

References (24)

1. Achenbach TM: Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington (Vermont), University of Vermont, 1991.
2. Benton D, Cook R: The impact of selenium supplementation on mood. Biol Psychiatry 29:1092-1098, 1991.
3. Benton D, Donohoe RT: The effects of nutrients on mood. Public Health Nutr 2:403-409, 1999.
4. Benton D, Griffiths R, Haller J: Thiamine supplementation mood and cognitive functioning. Psychopharmacology (Berl) 129:66-71, 1997.
5. Benton D, Haller J, Fordy J: Vitamin supplementation for 1 year improves mood. Neuropsychobiology 32:98-105, 1995.
6. Burlingame GM, Wells MG, Hoag MJ, Hope CA, Nebeker RS, Konkel K, McCollam P, Peterson G, Lambert MJ, Latkowski M, Ferre R, Reisinger CW: Administration and Scoring Manual for the YOQ 2.0. Stevenson (Maryland), American Professional Credentialing Services, 1998.
7. Carroll D, Ring C, Suter M, Willemsen G: The effects of an oral multivitamin combination with calcium, magnesium, and zinc on psychological well-being in healthy young male volunteers: A double-blind placebo-controlled trial. Psychopharmacology (Berl) 150:220-225, 2000.
8. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale (New Jersey), Lawrence Erlbaum, 1988.
9. Dubovsky S, Thomas M, Hijazi A, Murphy J: Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci 243:229-234, 1994.
10. Dunlop WP, Cortina JM, Vaslow JB, Burke MJ: Meta-analysis of experiments with matched groups or repeated measures designs. Psychol Methods 1:170-177, 1996.
11. Gesch CB, Hammon SM, Hampson SE, Eves A, Crowder MJ: Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. Br J Psychiatry 181:22-28, 2002.
12. Hoffer A: Vitamin B-3 and Schizophrenia. Kingston (Ontario), Quarry Press, 1999.
13. Kaplan BJ, Crawford SG, Gardner B, Farrelly G: Treatment of mood lability and explosive rage with minerals and vitamins: Two case studies in children. J Child Adolesc Psychopharmacol 12:203-218, 2002.
14. Kaplan BJ, Simpson JS, Ferre RC, Gorman CP, McMullen DM, Crawford SG: Effective mood stabilization with a chelated mineral supplement: An open-label trial in bipolar disorder. J Clin Psychiatry 62:936-944, 2001.
15. Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R: Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42:349-358, 1997.
16. Mash EJ, Terdal LG: Assessment of child and family disturbances: A behavioral-systems approach. In: Assessment of Childhood Disorders. Edited by Mash EJ, Terdal LG. New York, Guilford Press, 1997, pp 3-68.
17. Nemets B, Stahl Z, Belmaker RH: Addition of omega-3 fatty acid to maintenance of medication treatment for recurrent unipolar depressive, disorder. Am J Psychiatry 159:477-479, 2002.
18. Peet M, Horrobin DF: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59:913-919, 2002.
19. Popper CW: Do vitamins or minerals (apart from lithium) have mood-stabilizing effects? [commentary]. J Clin Psychiatry 62:933-935, 2001.
20. Richardson AJ, Puri BK: A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry 26:233-239, 2002.
21. Sandstead HH, Penland JG, Alcock NW, Dayal HH, Chen XC, Li JS, Zhao F, Yang JJ: Effects of zinc and other micronutrients on neuropsychologic performance and growth of Chinese children. Am J Clin Nutr 68:470S-475S, 1998.
22. Schoenthaler SJ, Bier ID: The effect of vitamin-mineral supplementation on juvenile delinquency among American schoolchildren: A randomized, double-blind placebo-controlled trial. J Altern Complement Med 6:7-17, 2000.
23. Simmons M: Letter to the editor. J Clin Psychiatry 64:338, 2002.
24. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133:429-435, 1978.